Translocation (2;3)(p21;q26) as the Sole Anomaly in a Case of Primary Myelofibrosis-Reference-Cited by-同舟云学术

Translocation (2;3)(p21;q26) as the Sole Anomaly in a Case of Primary Myelofibrosis

Published:1999-04 Issue:1 Volume:110 Page:62-64
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Herens Christian,Hermanne Jean-Philippe,Tassin Francoise,Fassotte Marie France,Thiry Albert,Jamar Mauricette,Schaaf-Lafontaine Nicole,Fillet Georges,Koulischer Lucien

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference14 articles.

1. Translocation (2;3)(p22;q28) is associated with myeloid disorders;Berger;Cancer Genet Cytogenet,1995

2. Chromosomes in acute nonlymphocytic leukemia;Prigogina;Hum Genet,1986

3. t(2;3)(p23;q26) in a patient with AML M2;Levaltier;Br J Haematol,1996

4. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities;Whang-Peng;Blood,1988

5. 3q−, 3q+ anomaly in malignant proliferations in humans;Mecucci;Cancer Genet Cytogenet,1983

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The translocation (4;12)(q31;q21) in myelofibrosis associated with myelodysplastic syndrome: impact of the 12q21 breakpoint;Cancer Genetics and Cytogenetics;2006-01

2. EVI1is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements;Genes, Chromosomes and Cancer;2005-12-08

3. Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features;Leukemia;2004-04-15